Vision
HCG's TMT department is a Centre of Excellence that accelerates oncology research and improves patient treatments and outcomes using a collaborative approach, from bench to bedside and vice-versa.
Mission
TMT at HCG aims to establish a sustainable research enterprise for outcome-based research. It offers cost-effective clinical and non-clinical development services, putting HCG on the world map of oncology research.
Functioning
The department supports all the in-house basic and clinical translational research and has an international second opinion network for patient benefit worldwide. Apart from the in-house research activities the department functions as an interface with the Pharma-Biotech industry and makes HCG their preferred partner in oncology drug development programs across the product life cycles. The department has developed a close relationship with the "Indian Society for Clinical Research (ISCR)" as an Accredited Member Organisation of the society.
Below listed are our focus areas:
Translational oncology – solid tumours and haemato-oncology
Immuno-oncology
Precision immunotherapy
Cell-based therapies
Microbiome interactions
Tumour microenvironment interactions
Translational pathology and digital pathology
Genomic theragnostics (genotype-guided cancer therapy)
Diagnostics development and drug screening
Cancer infections
Preventive oncology, community engagement and population science
Integrative oncology
Regenerative medicine
The Department of Translational Medicine (TMT) provides services that promote a vibrant translational research and training environment at HCG.
